Kebilidi

eladocagene exuparvovec-tneq

Approval

ApplicationBLA 125722
Approval dateNov 13, 2024
Approval year2024
SponsorPTC Therapeutics

FDA-approved use

For the treatment of adult and pediatric patients with aromatic L amino acid decarboxylase (AADC) deficiency

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Kebilidi: